Ustar focuses on new generation of medical tests

Ustar Biotechnologies Ltd, a molecular diagnostic company, will step up its globalization and the development of second-generation testing technology, Chief Executive Officer You Qimin told China Daily.

"Our kits for tuberculosis diagnosis based on first-generation technology have been licensed in Indonesia and the Philippines, and sales will start this month," said You.

"We are doing clinical trials for the kits in India and promoting the process in Africa and Malaysia as well as with the World Health Organization," he said.